C9915
ω-Conotoxin GVIA
≥97% (HPLC)
登录 查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C120H182N38O43S6
化学文摘社编号:
分子量:
3037.35
MDL编号:
UNSPSC代码:
12352202
NACRES:
NA.32
质量水平
方案
≥97% (HPLC)
表单
powder
组成
Peptide content, ~70%
储存温度
−20°C
基因信息
human ... CACNA1B(774)
mouse ... CACNA1B(12287)
rat ... CACNA1B(257648)
正在寻找类似产品? 访问 产品对比指南
Amino Acid Sequence
Cys-Lys-Ser-Hyp-Gly-Ser-Ser-Cys-Ser-Hyp-Thr-Ser-Tyr-Asn-Cys-Cys-Arg-Ser-Cys-Asn-Hyp-Tyr-Thr-Lys-Arg-Cys-Tyr-NH2 [Disulfide Bridges: 1-16, 8-19, 15-26]
应用
ω-Conotoxin GVIA has been used as an antagonist for N-type calcium channel (CaV2.2) in various studies.
Powerful probe for exploring the vertebrate pre-synaptic terminal.
生化/生理作用
ω-Conotoxin GVIA is a 27 amino acid neurotoxin containing three disulfide bonds. It inhibits central neurotransmitter release and also exhibits antihypertensive, analgesic and neuroprotective activities.
Blocks specific voltage-dependent N-type Ca2+ channels in neurons, but not in muscle; does not bind to either the dihydropyridine or verapamil binding sites; peptide first isolated from the marine snail Conus geographus L.
其他说明
Lyophilized from 0.1% TFA in H2O
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
法规信息
高风险级别生物产品--毒素类产品
此项目有
Precursor structure of omega-conotoxin GVIA determined from a cDNA clone
Colledge CJ, et al.
Toxicon, 30(9), 1111-1116 (1992)
CaV2. 2 gates calcium-independent but voltage-dependent secretion in mammalian sensory neurons
Chai Z, et al.
Neuron, 96(6), 1317-1326 (2017)
Inhibition of central neurotransmitter release by omega-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel
Dooley DJ, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology, 336(4), 467-470 (1987)
Structure-function relationships of $\omega$-conotoxin GVIA Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogues
Lew MJ, et al.
The Journal of Biological Chemistry, 272(18), 12014-12023 (1997)
Cristina Pozzoli et al.
Current protocols in toxicology, Chapter 21, Unit 21-Unit 21 (2012-11-22)
The protocol detailed in this unit is designed to assess intestinal peristaltic motility in the isolated small intestine in vitro and to measure the effects of drugs able to interfere with gut propulsive activity. The procedure is based on Trendelenburg's
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持